Navigation Links
2013 Neurotech Leaders Forum to Feature Promising New Startups

SAN FRANCISCO, Sept. 23, 2013 /PRNewswire/ -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced that several startup and early stage neurotechnology companies will be presenting at the 2013 Neurotech Leaders Forum, to be held in San Francisco October 14-15 at the Radisson Hotel SFO.

These include Neuro Recovery Technologies, Inc., a Southern California neurorehabilitation startup cofounded by UCLA professor Reggie Edgerton. The company is developing a novel spinal cord stimulation system to promote rehabilitation and locomotion in individuals with spinal cord injury.

Also presenting is EnteroWave Inc., a Stanford University spinoff developing a neurostimulation system for the gastrointestinal tract, and Mainstay Medical, a European firm developing an implanted stimulation system for chronic low back pain. Another presenting firm is SynTouch LLC, a Southern California firm cofounded by Gerald Loeb, a professor at USC and one of the inventors of the Bion microstimulator.

Danny Sachs, M.D., a serial entrepreneur who has founded several neurotech and medical technology firms, will keynote the event on October 14. He will speak on fostering innovation in neurotechnology. The first day of the conference will be devoted to the market for implanted neurotech devices.

The second day will explore developments in noninvasive stimulation, neurosensing and diagnostics, consumer neurotech applications, and advances in brain-computer interfaces.

"This year's Neurotech Leaders Forum offers an excellent opportunity to see the very latest technology and market developments in both consumer and healthcare neurotech," said James Cavuoto, Editor and Publisher of Neurotech Business Report.

Speakers and panelists at the conference include venture capital professionals Roger Quy of Technology Partners, Manuel Lopez-Figueroa of Bay City Capital, and Kevin Wasserstein of Clinicians on the panel include Dan DiLorenzo, a neurosurgery fellow at Rush University, Graham Creasey, professor of neurosurgery at Stanford University School of Medicine, and Philip Kennedy of Emory University and Neural Signals Inc.

Other speakers include Eric Brelje from Medtronic's business development unit, Gary Heit, president of Heit Consulting, Victor Pikov from Huntington Medical Research Institutes, Ann Bunnenberg, CEO of Electrical Geodesics, and David Wood, CEO of Spinal Modulation Inc. Also speaking will be Jennifer French, a quadriplegic who won a Silver Medal in sailing at the 2012 Paralympic Games after receiving an implanted neurostimulation system.

Cirtec Medical Systems is Platinum Sponsor of the event. Micro Systems Technologies is the Gold Sponsor, and Stellar Technologies is the Silver Sponsor.

For more information, contact James Cavuoto at 415-546-1259 or visit

Photo 72dpi:

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at

SOURCE Neurotech Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
2. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
3. Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference
4. Day Two of AdvaMed 2013 to Feature Government and Industry Leaders on MedTech Challenges and Opportunities
5. Industry Leaders Drive SPIE Photomask Technology Conference
6. NineSigmas Non-Profit Guide to The Grand Challenge Empowers Non-Profit Leaders to Achieve their Mission while Amplifying Awareness of their Cause
7. Leadership as a Hero’s Journey Explores Four Virtues That Transform Uncertainty and Anxiety into Results, a New Book by Eric Kaufmann
8. Green Dot Holdings LLC CEO, Mark Remmert, Joins Industry Thought Leaders to Discuss Holistic Sustainable Design at A Better World by Design Conference
9. Adheron Therapeutics Names New Senior Leadership
10. Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
11. Paragon Bioservices Wins CMO Leadership Awards for Third Consecutive Year
Post Your Comments:
(Date:11/30/2015)... Israel , Nov. 30, 2015 ... leading developer of adult stem cell technologies for neurodegenerative diseases, ... has been awarded an additional grant of approximately $735,000 from ... (OCS). This grant, the second this year, brings the total ... $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... that it has closed the sale of its global ... (GBT- NYSE Euronext) in a transaction valued at approximately ... facilities and a total of approximately 1,000 employees spread ... St. Louis area. This entire workforce ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
Breaking Biology Technology:
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... an innovator in modern authentication and a founding member ... launch of its latest version of the Nok Nok™ ... to use standards-based authentication that supports existing and emerging ... Suite is ideal for organizations deploying customer-facing applications that ...
(Date:10/22/2015)... 2015  Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... third quarter ended September 30, 2015.  --> ... was $4.0 million, a decrease of 33% compared to $6.0 million ... quarter of 2015 was $2.2 million, or $0.10 per diluted share, ... the same period a year ago.  --> ...
Breaking Biology News(10 mins):